Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-20

Clinical Trial Update: Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis [NA]

View source ↗

Summary

Clinical trial update on the effective dose of etanercept in patients with Juvenile Idiopathic Arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Juvenile Idiopathic Arthritis | NA | Status: COMPLETED